baber/WOPTO huggingface dataset:
Patent NZ-581895-A (NZ)
Title: Magnetic mounting bracket for precast concrete sideforms
Inventor: SLADOJEVIC ROBERT
IPC: E04G17/04
Filed: 2007-10-31
Abstract: Disclosed is a sideform assembly (9) including a mounting bracket assembly for mounting the sideform to a substrate. A sideform (11) defines an attaching formation (13', 14') on an operatively rear wall (12). A mounting bracket assembly (10) comprises a connector plate (16) for supporting the sideform (11) and includes an engaging component (21) for engaging the attaching formation (13', 14') of the sideform (11). A mounting member (18) is carried by the connector plate (16) for mounting the connector plate (16) to the substrate. The mounting member is interchangeable so that different mounting members can be used to attach the sideform to different types of substrates.
Patent NZ-582441-A (NZ)
Title: Immunogenic composition for use in vaccination against staphylococcei
Inventor: CASTADO CINDY
IPC: A61P31/04
Filed: 2005-09-20
Abstract: Disclosed is the use of an immunogenic composition comprising a staphylococcal transporter protein and a staphylococcal regulator of virulence or toxin in the manufacture of a vaccine for treating or preventing a staphylococcal infection. The staphylococcal transporter protein is selected from: Immunodominant ABC transporter, IsdA and IsdB. The staphylococcal regulator of virulence or toxin is selected from: alpha toxin (Hla) or alpha toxin H35R mutant. The immunogenic composition can further comprise a staphylococcal extracellular component selected from: SdrG, laminin receptor, EbhA, EbhB, Elastin binding protein (EbpS), EFB (FIB), SBI, autolysin, ClfA, SdrC, SdrH, Lipase GehD, SasA, FnbA, FnbB, Cna, ClfB, FbpA, Npase, IsaA/PisA, SsA, EPB, SSP-1, SSP-2, HBP Vitronectin binding protein, coagulase and MAP. The vaccine can be used to protect against Staphyloccocus aureus and S. epidermidis.
Patent NZ-592659-A (NZ)
Title: Composed element, multi -layered board and panel-shaped element for forming this composed element
Inventor: MAERTENS LUC
IPC: A47B96/20
Filed: 2009-10-29
Abstract: 592659 A composed element comprising at least two panel-shaped elements (2, 3), which each have an edge zone (4, 5) in which coupling means (6, 7) are present in the form of a profiled part respectively extending in the longitudinal direction of the respective edge zone. Each element (2, 3) has an end face (10, 11) extending transversely to the respective edge zone (4, 5); with the profiled parts allow coupling the panel-shaped elements (2, 3) together in an interlocking manner. At least one of the panel-shaped elements (2, 3) has a strip of covering material (21, 22) which hides from view at least a portion of the profiled part formed at the pertaining edge zone (4, 5) at the location of the end face (10, 11). Each strip (21, 22) is joined to the respective panel (2, 3) prior to joining the panels (2, 3) together.
Patent NZ-593133-A (NZ)
Title: Controlling load provided to an appliance at a socket by communication with a power system
Inventor: THOMSON MATTHEW
IPC: H02J3/14
Filed: 2011-05-27
Abstract: A system 26 to control the amount of power supplied to individual loads 22, 28 so as to be able to have a finer degree of control of load shedding includes a load control module 50 to control the amount of power transmitted to a particular load plugged into outlet 58, to receive a power control command from a power system, and to transmit a power control acknowledgement to the power system. The system also includes a load monitoring module 52 that determines the amount of power supplied to the load and transmits a value representing the determined amount to the power system. The monitoring and control device may be implemented in the form of a wall socket.
Patent NZ-595849-A (NZ)
Title: Rotor blade, rotor blade element and production method
Inventor: MUSCHKE SVEN
IPC: B29C70/44
Filed: 2010-04-13
Abstract: 595849 The disclosure relates to a rotor blade element for a wind turbine, to the rotor blade and to a production and repair method for the rotor blade element and the rotor blade. The disclosure also relates to a wind turbine comprising a corresponding rotor blade or rotor blade element. The repair process includes the steps: a) providing a fibre material at a rotor blade element, b) covering the fibre material with a surface film, c) optionally providing the fibre material covered with the surface film with a moulding body, and d) sucking gas out of the fibre material, e) acting on the fibre material with a hardenable resin, and f) reacting the hardenable resin with the surface film.
Patent NZ-596291-A (NZ)
Title: A connection element
Inventor: TAYLOR WILLIAM
IPC: B60R5/04
Filed: 2010-04-20
Abstract: This disclosure relates to a connection element for effecting connection between a vehicle component or accessory and a vehicle, the connection element comprising at least first and second connection points, and means integral with the connection element which are adapted to absorb tensile impact loading imparted upon the element via means other than lengthening of the connection element solely.
Patent NZ-596390-A (NZ)
Title: Indole derivative modulators of the alpha 7 nachr
Inventor: DINNELL KEVIN
IPC: A61K31/4045
Filed: 2010-04-14
Abstract: 596390 Disclosed herein is a compound of formula I, wherein the variables are defined in the specification, and the use thereof in the treatment of a psychotic disorder, such as schizophrenia or cognitive impairment. Examples of the compound include the following: N-{ [7-[2-(methyloxy)-3-pyridinyl]-2-(trifluoromethyl)-1H-indol-5-yl]methyl} -6-(trifluoromethyl)-3-pyridinecarboxamide, and N-{ [7-(1-methyl-1H-imidazol-2-yl)-2-(trifluoromethyl)-1H-indol-5-yl]methyl} -6-(trifluoromethyl)-3-pyridinecarboxamide
Patent NZ-597200-A (NZ)
Title: Population scale hla-typing and uses thereof
Inventor: HOGAN MICHAEL E
IPC: C07H21/04
Filed: 2011-12-19
Abstract: 597200 POPULATION SCALE HLA-TYPING AND USES THEREOF Provided is a set of hybridization probes with defined sequences for HLA typing of single nucleotide polymorphisms (SNPs) in HLA-B exon 2 or exon 3. Further provided are microarray and devices using the probes/microarray in fast HLA typing of individuals.
Patent NZ-598670-A (NZ)
Title: Antibodies against glucagon receptor and their use
Inventor: LEE EUNKYUNG
IPC: C07K16/28
Filed: 2009-09-08
Abstract: Disclosed is an isolated antibody, or an antigen-binding portion or a derivative thereof, comprising: (a) a first CDR set, CDR1, CDR2 and CDR3, that sequentially together comprises the amino acid sequences of heavy chain variable region CDRs, CDR1, CDR2 and CDR3, sequentially together, that are included in the amino acid sequence as set forth in any one of SEQ ID Nos. 2, 4, 6, 8, 10, 12, 14, and 16, or antigen-binding fragments thereof; and (b) a second CDR set, CDR1, CDR2 and CDR3, that sequentially together comprises the amino acid sequences of light chain variable region CDRs, CDR1, CDR2 and CDR3, sequentially together, that are included in the amino acid sequence as set forth in any one of SEQ ID Nos. 18, 20, 22, 24, 26, 28 and 30, or antigen-binding fragments thereof, wherein said antibody or antigen binding portion binds to glucagon receptor, and wherein the sequences are as disclosed in the complete specification. Also disclosed is the use of said antibody in the manufacture of a medicament for lowering blood glucose, improving glucose tolerance, or for treating, preventing or inhibiting type II diabetes, dyslipidaemia or related disease in a subject in need thereof.
Patent NZ-601175-A (NZ)
Title: Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
Inventor: SUGIYAMA HARUO
IPC: C12N5/0786
Filed: 2007-12-14
Abstract: Disclosed is a peptide having an ability to bind to an HLA-A*1101 molecule, and an ability to induce a cytotoxic T lymphocyte (CTL), the peptide consisting of the amino acid sequence Thr Gly Val Lys Pro Phe Gln Cys Lys, in which one to five amino acid(s) are substituted. Also disclosed are peptide dimers, the use of the peptides in the manufacture of a medicament, expression vectors, pharmaceutical compositions, WT1-specific cytotoxic T lymphocyte, wherein said cytotoxic T lymphocyte has been induced by the peptide and methods for induction of WT1-specific cytotoxic T lymphocytes.
Patent NZ-602654-A (NZ)
Title: Topical sunscreen compositions
Inventor: DALY SUSAN
IPC: A61Q17/04
Filed: 2012-09-26
Abstract: 602654 Disclosed is a composition comprising: at least 10% by weight of a C2 or C3 mono-alcohol (ethanol or propanol); a solid organic UV-filter (oxybenzone) dissolved therein; an oil portion comprising one or more oils, the oil portion comprising one or more oils selected from the group consisting of oils having a carbon chain of at least four carbons in which none of the four carbons is a carbonyl carbon and oils having two or more oxypropylene groups in sequences miscible with the C2 or C3 mono-alcohol, wherein the oil portion has an interfacial tension with water of greater than 9mN/m and less than 45mN/m, and wherein the composition has a volume fraction of the oil portion relative to the oil portion plus the C2 or C3 mono-alcohol that is greater than 0.47, and wherein the composition is substantially free of a mixture of a low-volatility, C2 – C8 liquid silicone and a branched fatty acid ester of a polyprotic carboxylic acid in a ratio of from about 3:1 to 4.25:1, and wherein the composition comprises less than 1 percent by weight water.
Patent NZ-604057-A (NZ)
Title: Plant cytochrome p450
Inventor: WINZER THILO
IPC: C12N15/82
Filed: 2011-07-18
Abstract: An isolated nucleic acid molecule that encodes a cytochrome P450 polypeptide wherein said nucleic acid molecule comprises or consists of a nucleotide sequence selected from the group consisting of: i) a nucleotide sequence as represented by the sequence in Figure 1c, 1d or 3c; ii) a nucleotide sequence wherein said sequence is degenerate as a result of the genetic code to the nucleotide sequence defined in (i); iii) a nucleotide sequence having at least 80 % identity to the sequences represented in Figure 1c or 1d or 3c wherein said nucleic acid molecule encodes a cytochrome P450 polypeptide; iv) a nucleotide sequence that encodes a polypeptide comprising an amino acid sequence as represented in Figure 4c ; v) a nucleotide sequence that encodes a modified polypeptide comprising an amino acid sequence which is at least 45% identical to the full length amino acid sequence in Figure 4c and which has retained or enhanced cytochrome P450 activity.
Patent NZ-609370-A (NZ)
Title: Synthetic gene for expressing sm-14 in pichia pastoris, methods for producing and purifying sm-14 and the use thereof as a vaccine and diagnostic medium
Inventor: RAMOS CELSO RAUL ROMERO
IPC: C12N15/79
Filed: 2011-09-13
Abstract: Discloses a nucleic construct of Sm14, a production process for producing recombinant Sm14 in Pichia pastoris, a purification method and the subsequent use of the Sm14 protein to control infections caused by parasites (such as helminths).
Patent NZ-613110-A (NZ)
Title: Humidifier
Inventor: FOOTE ROGER MERVYN LLOYD
IPC: H05B3/00
Filed: 2012-01-24
Abstract: Disclosed is a humidifier; a respiratory apparatus; a method of humidifying breathable gas; an air heater coil; a method of heating air flow within a respiratory device; a method of controlling a humidifier and a method of treating a respiratory disorder of a patient. A humidifier (12) can be used to treat sleep disordered breathing with continuous positive airway pressure. Current devices for humidifying air supply are cumbersome and prone to spillage. The humidifier comprises a heating element and outer housing (26). The heating element includes a porous structure (24) of electrically resistive and thermally conductive material configured to vaporise liquid which is passed through the porous structure. The porous structure has a liquid inlet (28) and a vapour outlet. The outer housing surrounds at least a portion of the porous structure for containing the liquid and vapour within the porous structure. The porous structure includes a first (33) and second (37) electrical connectors configured to receive electrical power and apply a voltage across the porous structure.
Patent NZ-616907-A (NZ)
Title: Oral complex composition comprising omega-3 fatty acid ester and hmg-coa reductase inhibitor
Inventor: PARK JAE HYUN
IPC: A61K47/48
Filed: 2012-03-23
Abstract: The disclosure relates to an oral complex composition comprising omega-3 fatty acid esters and HMG-CoA reductase inhibitor, which can effectively raise serum HDL level while reducing serum LDL and TG levels and can be used to treat hyperlipidemia owing to its good drug dissolution rate and storage stability with showing no delayed release behavior even after 6 months of accelerated storage. The oral complex composition comprises: (a) a soft capsule core comprising omega-3 fatty acid esters; (b) a first coating layer which encases the soft capsule core and comprises a hydrophobic coating material selected from the group consisting of cellulose acetate, polyvinyl acetate, ethyl cellulose, (meth)acrylic acid copolymers and a mixture thereof; and (c) a second coating layer deposited on the first coating layer, which comprises: (i) rosuvastatin or a pharmaceutically acceptable salt thereof, and (ii) polyvinyl alcohol, polyvinyl alcohol-polyethylene glycol graft copolymer or a mixture thereof.
Patent NZ-617345-A (NZ)
Title: Flat key for a locking cylinder and locking cylinder
Inventor: KORNHOFER MARKUS
IPC: E05B27/00
Filed: 2012-03-19
Abstract: A flat key (1) and cylinder is disclosed. The key comprising a key back and a toothed key bit arranged opposite same, for positioning sprung core and housing rods in the locking cylinder. The flat key comprises respectively at least two grooves (2, 3) on one or both flat sides, the grooves engaging in each other from the flat side and overlapping each other with divergent groove directions. The two overlapping grooves (2, 3) are undercut in opposite directions in such a way that, as a result of the undercuts (8), in at least one groove (2) the centre (4) of the groove base is covered in the direction normal to the longitudinal central plane (6). The intersection of the two grooves (2, 3) provides an edge (5) having a traceable position. The overlapping grooves (2, 3) can overlap with an opposing groove (42) as a guiding profiled groove in relation to the longitudinal central plane (6). The edge (5) inside the overlapping grooves (2, 3) can be flattened to form a bearing surface (Fig 3 - 5’) for a tracing element (Fig 5 - 11, Fig 6 - 12) in the locking cylinder.
Patent NZ-624594-A (NZ)
Title: Urease inhibitor formulations
Inventor: PHILLIP ARPAD T
IPC: C05G3/90
Filed: 2012-11-13
Abstract: Provided are liquid urease inhibitor formulations comprising a N-substituted thiophosphoric triamide or a N-substituted phosphoric triamide compound of Structure I as the urease inhibitor, and a dialkyl sulfone of Structure II or a polymethylene cyclic sulfone of Structure III as the solvent. The variables are as defined in the specification.
Patent NZ-626508-A (NZ)
Title: Bracket for a roofing guard rail and a method of manufacture thereof
Inventor: EMSLIE KARL DAVID
IPC: E06C7/18
Filed: 2012-07-19
Abstract: An edge protection system (20) is disclosed. The system includes a plurality of brackets (1) with at least one guard rail (27) spanning between the brackets. Each bracket includes a main body having a mounting portion to engage with a building and including at least two bearing surfaces, an upright portion, including at least one flange extending laterally from the upright portion, and a releasable fastener mounted to the flange, configured to releasably secure a guard rail to the bracket. The main body and upright portion are manufactured from flat sheet material. This is advantageous in ease and speed of manufacture, reduced weight, and ease of transportation and storage. A method of installing an edge protection system and a method of manufacturing a bracket is also disclosed.
Patent NZ-630483-A (NZ)
Title: Compounds and methods for kinase modulation, and indications therefor
Inventor: IBRAHIM PRABHA N
IPC: A61P35/00
Filed: 2013-03-18
Abstract: Disclosed is the use of Pexidartinib (5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-{ [6-(trifluoromethyl)-3-pyridinyl]methyl} -2-pyridinamine) in the manufacture of a medicament for the treatment of pigmented villonodular synovitis (PVNS), tenosynovial giant cell tumour (TGCT), plexiform neurofibromasin and in combination with sirolimus for the treatment of malignant peripheral nerve sheath tumours (MPNST). Also disclosed are methods of using protein kinase inhibitors for treating diseases and conditions, including diseases and conditions associated with activity of any protein kinase selected from Fms protein kinase including any mutations thereof, Kit protein kinase any mutations thereof, Flt-3 protein kinase any mutations thereof and combinations thereof. The compounds used have a pyrrolo[2,3-b]pyridine core structure.
Patent NZ-701623-A (NZ)
Title: Use of protease to remove bacterial biofilm
Inventor: SHI LEI
IPC: A61P17/02
Filed: 2013-05-10
Abstract: Disclosed are compositions and methods for their use in disrupting a bacterial biofilm present on a surface, comprising applying a composition that includes Seaprose to the bacterial biofilm, wherein application of the composition to the bacterial biofilm disrupts the matrix of the bacterial biofilm.
Patent NZ-702142-A (NZ)
Title: System and method for multi-dimensional knowledge representation
Inventor: GALASSI CHRISTOPHER R
IPC: G06F17/00
Filed: 2011-08-05
Abstract: Disclosed is a computer-implemented method. A graphic display displays an editing interface (14) for creating a custom version of a configurable document (12) that comprises a collection of subparts (16, 18, 20). One or more of the subparts (16, 18, 20) comprises a plurality of dimensions, the editing interface (14) provides for selection of a particular predefined version of the configurable document (12) from a plurality of predefined versions of the configurable document (12) and each predefined version comprises a subset of the collection of subparts (16, 18, 20). A version-selection instruction is received via editing interface (14) that indicates a selected predefined version of the configurable document (12) from the plurality of predefined versions. In response to the version-selection instruction, the graphic display displays the collection of subparts (16, 18, 20) in the editing interface (14), and visually indicates in the editing interface (14) which subparts (16, 18, 20) from the collection are included in the selected predefined version. One or more sub-part selection instructions are then received via the editing interface (14) that indicates to select or de-select an individual subpart from the collection of subparts (16, 18, 20). Then, one or more dimension-selection instructions are received via the editing interface (14) that indicates to select a particular dimension for one or more of the selected subparts (16, 18, 20). Finally, a document-generation instruction is received and a custom version of the configurable document (12) is responsively generated. The custom version includes the selected dimension for each of the one or more subparts (16, 18, 20) that are selected in the editing interface (14).
Patent NZ-702906-A (NZ)
Title: Methods and compositions for biomethane production.
Inventor: JENSEN JACOB WAGNER
IPC: C12P5/02
Filed: 2013-06-12
Abstract: Methods of processing municipal solid wastes (MSW) are provided whereby concurrent enzymatic hydrolysis and microbial fermentation of wastes results in liquefaction of biodegradable components as well as accumulation of microbial metabolites. Liquefied biodegradable components are then separated from nondegradable solids to produce a bioliquid characterized in comprising a large percentage of dissolved solids of which a large fraction comprises some combination of acetate, ethanol, butyrate, lactate, formate or propionate. This bioliquid is, itself, a novel biomethane substrate composition, which permits very rapid conversion to biomethane. Methods of biomethane production are further provided using this bioliquid and using other biomethane substrate compositions produced by concurrent enzymatic hydrolysis and microbial fermentation of organic materials.
Patent NZ-718357-A (NZ)
Title: Method of demand management and control of fluid pipe networks
Inventor: AUGHTON DAVID
IPC: G06F17/00
Filed: 2014-09-04
Abstract: The invention discloses a method of demand management and control of limited pressure head or gravity fed fluid pipe networks. The method includes the steps of providing a computer controlled fluid network for delivery of fluid through a plurality of valves, maintaining a real time database within said computer controlled fluid network of predetermined parameters including flow schedules and capabilities of the plurality of valves, requesting, through a user interface, a flow rate and time of delivery of said fluid from the fluid network to at least one of plurality of valves, determining, using the predetermined parameters from real time database, the availability of providing delivery and flow rate of fluid from the fluid network to the at least one of said plurality of valves based on hydraulic capacity of the fluid network, and, if the hydraulic capacity is available, calculating parameters using the real time database to deliver fluid to the at least one of said plurality of valves through said computer controlled fluid network, whereby each of the plurality of valves is monitored and adjustably controlled to provide the flow rate and delivery through the at least one of said plurality of valves in unison with the monitoring and controlling of the others of the plurality of valves to maintain the flow and manage the pressure head within fluid pipe network between predetermined limits.
Patent NZ-721936-A (NZ)
Title: Retail fueling environment utilizing powered communication over legacy cabling
Inventor: MCNINCH WAYNE
IPC: H02J9/00
Filed: 2013-10-22
Abstract: Various systems and methods are provided for facilitating powered communications over legacy cabling. This can be implemented in a fuel dispensing environment where the fuel dispenser can include a diode coupler communicatively coupled to the legacy cabling for receiving powered communications from one or more backroom components over the legacy cabling during a power outage, and a broadband communications modem for communicating with the one or more backroom components, wherein the diode coupler provides power from the powered communications to the broadband communications modem. Relays can be used at the fuel dispenser and/or backroom components to determine whether to use the powered communications or legacy communications based on whether power is available at the components communicating over the legacy cabling. In addition, failsafe protection of legacy communication circuits is provided when powered communications are active.
Patent NZ-727213-A (NZ)
Title: Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides
Inventor: KENNEDY ROBERT
IPC: C12N15/82
Filed: 2013-03-08
Abstract: Disclosed is a peptide comprised of an Endoplasmic Reticulum Signal Peptide (ERSP) operably linked to one or more Inhibitor Cysteine Knot (ICK) peptides wherein the ERSP is positions on the N-terminal portion of said peptide and wherein the ERSP is a natural plant derived ESRP.
Patent NZ-752783-A (NZ)
Title: Functional composition and uses thereof
Inventor: Angus Ross Brown
IPC: A61P25/26
Filed: 2017-11-16
Abstract: The present invention relates to a functional composition and uses thereof, and in particular towards a composition that maintains or improves mental clarity. The composition includes a combination of at least 150 mg of blackcurrant, or an extract thereof, containing anthocyanin(s); and an effective amount of L-theanine. The invention also relates to methods of use and treatment of said composition.